Background Image
Table of Contents Table of Contents
Previous Page  11 / 132 Next Page
Information
Show Menu
Previous Page 11 / 132 Next Page
Page Background

Policy and

Organization

Food

Management

Medicinal

Products

Management

Controlled

Drugs

Management

Medical

Devices

Management

Risk Assessment

Management and

Research Outcomes

Cosmetics

Management

Appendix

National

Laboratory and

Testing Network

Risk Communication

and Consumer

Protection

International

Cooperation and

Cross-Strait Exchange

2015 Annual Report

11

Section 3. Future Prospects

Trends in food products, medicinal products, and cosmetics safety management as well

as medicinal product review and food safety management are closely related to industrial

KL]LSVWTLU[ ;-+( HK]HUJLKS` JVU[PU\LZ [V YL]PZL SH^Z HUK PTWSLTLU[ THUHNLTLU[ M\[\YL

developments in order to strengthen production source controls, food hygiene laws, as well as

MVVK ZV\YJL PTWVY[LK WYVK\J[ HUK YH^ TH[LYPHSZ THUHNLTLU[ ;-+( HSZV JHYYPLZ V\[ IVYKLY

inspections and strengthen food safety monitoring in order to provide a safe food consumer

environment for fellow citizens.

;V WYV]PKL TLKPJPUHS WYVK\J[Z ^P[O [OL YLX\PYLK ZHML[` HUK X\HSP[` HZZ\YHUJL ;-+( ZOHSS

continue to enhance production quality and ensure proper management, strengthen the

comprehensiveness of pharmaceutical regulations, establish medicinal product review systems

aligned with those adopted worldwide, implement medicinal product source management,

strengthen the suppression of illegal drugs and illicit advertisements, and enhance the

management of controlled drugs.

;V ZHMLN\HYK JVUZ\TLY KY\N JVUZ\TW[PVU HUK JVZTL[PJZ ZHML[` ;-+( ZOHSS HJOPL]L LMMLJ[P]L

THUHNLTLU[ VM WYVK\J[Z HUK YH^ TH[LYPHS KPZ[YPI\[PVU HZ ^LSS HZ Z[YLUN[OLU WVZ[ THYRL[

management of products such as by expanding quality monitoring plans and conducting multi-

JV\U[` JP[` VY HNLUJ` QVPU[ H\KP[Z TVUP[VYPUN IV[O KVTLZ[PJ HUK PU[LYUH[PVUHS WYVK\J[ ^HYUPUNZ

recalls of nonconforming medicinal products and cosmetics, reports of adverse reactions, and

JVUK\J[ YPZR JVTT\UPJH[PVU MVY JVUZ\TLY ZHML[` -\[\YL LMMVY[Z HUK KPYLJ[P]LZ VM ;-+( HYL

follows:

,Z[HISPZO THUHNLTLU[ YLN\SH[PVUZ OHYTVUPaLK ^P[O NSVIHS Z[HUKHYKZ [V WYVTV[L IPV[LJOUVSVN`

industry development.

0TWSLTLU[ MVVK HKKP[P]L ZV\YJL THUHNLTLU[ HUK PTWYV]L MVVK WYVK\J[PVU X\HSP[`

,Z[HISPZO H JVTWYLOLUZP]L TLKPJPUHS WYVK\J[ ZHML[` UL[^VYR [V ZHMLN\HYK KY\N \ZL ZHML[` VM

citizens.

,_WHUK THYRL[ H\KP[ HUK X\HSP[` TVUP[VYPUN [V Z[YLUN[OLU JVUZ\TLY WYV[LJ[PVU

(J[P]LS` WHY[PJPWH[L PU PU[LYUH[PVUHS VYNHUPaH[PVUZ [V L_WHUK PU[LYUH[PVUHS MVVK HUK KY\N

partnerships and opportunities.